Novo Nordisk A/S

Novo Nordisk A/S

NVO · NYSE
NVO · NYSE
37.82
USD-1.09-2.81%

Data

Tickers

Título

Fonte

    *NOVO NORDISK STARTS MULTI-MONTH SUBSCRIPTION PROGRAM FOR WEGOVY $NVO https://t.co/mM14BZXQB3

    Investingcom
    @Investingcom

      *NOVO AND HIMS END FEUD, WILL SELL OBESITY DRUGS TOGETHER $NVO $HIMS https://t.co/RvbLhOWfuZ

      Investingcom
      @Investingcom

        *NOVO NORDISK TO CUT OZEMPIC, WEGOVY'S US LIST PRICES BY UP TO 50%: WSJ $NVO https://t.co/fBJ05M6MNr

        Investingcom
        @Investingcom

          STARTS NOW! Rebel's Edge 1pm 🕐 $VNDA $ACLX $NVO $DPZ 🏈 NAJARIAN SPORTS 🏴‍☠️ with @petenajarian Winter Olympics: Hockey Finals was scripted perfectly, but did it reach 1980 levels? NFL: Chicago Bears, will they need to change the team's name? Indiana looking to build a Dome, NW https://t.co/CUnDFsQQz7

          MarketRebels
          @MarketRebels

            *NOVO NORDISK SINKS 15% AFTER WEIGHT LOSS DRUG FAILS TO MATCH ELI LILLY'S IN TRIAL $NVO $LLY https://t.co/xRsnosJ0yS

            Investingcom
            @Investingcom

              4 stocks to watch on Monday: LLY, NVO, APO, TTE

              SeekingAlpha

                *NOVO NORDISK SHARES SINK AFTER SALES OUTLOOK MISSES FORECAST $NVO https://t.co/NYcHbsSOue

                Investingcom
                @Investingcom

                  📅IT’S A BIG WEEK OF EARNINGS! 📈 $GOOGL $AMZN $AMD $PLTR $QCOM $ARM $SMCI $RDDT $RBLX $SNAP $PYPL $AFRM $UBER $DIS $PEP $CMG $TSN $LLY $NVO $PFE $MRK $COP $SHEL $B WILL DELIVER RESULTS! 💰MAKE SMARTER INVESTMENT DECISIONS WITH ‘PRO PICKS AI’: 🎁GET 50% OFF ALL PRO PLANS FOR https://t.co/hCLP39WM0n

                  Investingcom
                  @Investingcom

                    4 stocks to watch on Monday: NVO, PANW, OKTA, TWLO

                    SeekingAlpha

                      *NOVO NORDISK EXTENDS GAIN TO 10% AS WEGOVY PILL APPROVED IN US $NVO https://t.co/HTqEikpfvR

                      Investingcom
                      @Investingcom

                        *NOVO NORDISK SHARES PLUNGE 10% AFTER ALZHEIMER’S DRUG TRIAL FAILS TO HIT KEY TARGET $NVO https://t.co/TRBNffy1K5

                        Investingcom
                        @Investingcom

                          STARTS NOW! Rebel's Edge 🏴‍☠️ 1pm Stocks $DAY $NVO $WULF $EQT 🏈NAJARIAN SPORTS with @petenajarian Best Week 1, 2, 3 of College Football Biggest schools playing each other Heisman way to early read: I have a dark horse, but Arch is sitting at the top https://t.co/j2t4k86P3o

                          MarketRebels
                          @MarketRebels

                            *NOVO NORDISK SHARES PLUNGE 20% AFTER CUTTING FULL-YEAR GUIDANCE, NAMING NEW CEO $NVO https://t.co/xg8Nvsv4mD

                            Investingcom
                            @Investingcom

                              *NOVO NORDISK CEO TO STEP DOWN IN A SURPRISE MOVE $NVO https://t.co/JVN0yjXC6c

                              Investingcom
                              @Investingcom

                                Premarket Mover: $CVS +8% ✅ Q1 beats on top & bottom line 🛑 Exiting individual ACA insurance (#Obamacare) 🤝 Teams up with $NVO to boost access to weight-loss drug #Wegovy https://t.co/i9HgDC7DhN

                                SeekingAlpha
                                @SeekingAlpha

                                  Shares of Hims & Hers Health $HIMS are up double digits after the telehealth company announced a partnership with Novo Nordisk $NVO to sell the Danish drugmaker’s popular weight loss therapy, Wegovy. #Wegovy #WeightLoss #Healthcare #MarketWatch https://t.co/P3l230QDgw

                                  SeekingAlpha
                                  @SeekingAlpha

                                    *NOVO NORDISK’S DIABETES PILL SLASHES RISK OF CARDIOVASCULAR COMPLICATIONS BY 14% AFTER FOUR YEARS $NVO https://t.co/aUPHWSp1f5

                                    Investingcom
                                    @Investingcom

                                      Novo Nordisk reported full-year revenue of $40.5B, up 25% compared to 2023 Wednesday. For Q4 $NVO reported $11.6B in revenues, up 30% compared to the same quarter in 2023. The company's blockbuster semaglutide drugs, Wegovy for weight loss and Ozempic for diabetes, were key… https://t.co/lTuClsWXaK https://t.co/7h4Uvwelz2

                                      YahooFinance
                                      @YahooFinance

                                        ⚠️ JUST IN: *NOVO NORDISK BEATS EARNINGS ESTIMATE AS WEGOVY WEIGHT LOSS DRUG SALES JUMP 107% IN Q4 $NVO +3.6% https://t.co/vtyL7vyC4H

                                        Investingcom
                                        @Investingcom

                                          🎉ANOTHER BIG EARNINGS WEEK IS UPON US! 💰 $GOOGL $AMZN $AMD $ARM $QCOM $PLTR $SNAP $DIS $PYPL $LLY $PFE $MRK $NVO $UBER $F $RACE $TM $PEP $CMG ARE ALL SET TO DELIVER RESULTS! 📈PLAN EARLY WITH ALL KEY DATA IN 1 PLACE: https://t.co/Zh3sZIRv6K 👈 https://t.co/0Zont0zt9H https://t.co/JTwOtijLxx

                                          Investingcom
                                          @Investingcom

                                            "Denmark stock market -20% since Sept 24 driven by Novo Nordisk -40%... NVO was 60% of stock market; best reminder of concentration risk" - BofA's Hartnett https://t.co/QMb8bJr6A4

                                            zerohedge
                                            @zerohedge

                                              ⚠️BREAKING: *NOVO NORDISK STOCK PLUNGES 16% AFTER WEIGHT-LOSS DRUG DATA DISAPPOINTS; RIVAL ELI LILLY JUMPS 5% $NVO $LLY https://t.co/3v081kCR1V

                                              Investingcom
                                              @Investingcom

                                                STARTS NOW! Rebel's Edge 🏴‍☠️1pm line up: Fed speak 🗣️ and ongoing inflation concerns. $NVO $PARA $TSLA $ARDX Sports @petenajarian 🏈 #NFL Sleeper team for NFC Atlanta, if Cousins is healthy, that offense will roll https://t.co/W9YiylSHZi

                                                MarketRebels
                                                @MarketRebels

                                                  ⚠️ JUST IN: *NOVO NORDISK SHARES JUMP 4% TO HIT NEW RECORD HIGH AS  WEGOVY GETS APPROVAL IN CHINA ARE YOU BUYING OR SELLING? $NVO https://t.co/n5ugypCcym

                                                  Investingcom
                                                  @Investingcom

                                                    ⚠️ JUST IN: *NOVO NORDISK TOPS EARNINGS ESTIMATE, RAISES OUTLOOK FUELLED BY SOARING OBESITY DRUG DEMAND $NVO https://t.co/h8x2y31Zhg

                                                    Investingcom
                                                    @Investingcom

                                                      ⚠️BREAKING: *NOVO NORDISK STOCK SOARS TO A NEW RECORD AS IT TOUTS THE POTENTIAL OF ITS NEXT-GEN OBESITY TREATMENTS $NVO https://t.co/wHxSn00a1w

                                                      Investingcom
                                                      @Investingcom

                                                        ⚠️ JUST IN: *NOVO NORDISK, THE OBESITY DRUG MAKER, BECOMES THE SECOND-EVER EUROPEAN COMPANY TO REACH A $500 BILLION MARKET VALUE $NVO https://t.co/AzkbwhSOP7

                                                        Investingcom
                                                        @Investingcom

                                                          ⚠️BREAKING: *NOVO NORDISK’S WEIGHT LOSS DRUG WEGOVY SLASHES RISK OF SERIOUS HEART EVENTS, INCLUDING HEART ATTACK AND STROKE $NVO https://t.co/zpTx6CWWar

                                                          Investingcom
                                                          @Investingcom

                                                            #earnings before the open tomorrow https://t.co/lObOE0dgsr $MRNA $RCL $DDOG $BUD $PTON $W $NVO $COP $PARA $SHEL $PLNT $K $RACE $REGN $PENN $CG $CAH $H $ATI $AUYTL $LNTH $PZZA $ARGX $ZTS $DINO $SHAK $AUPH $BHC $STWD $TGLS $BWA $PCG $SWK $FOUR $AG $PRVA $AEP $NFE $EQNR $PH $CMRX… https://t.co/ZdNHGu9zTe

                                                            eWhispers
                                                            @eWhispers

                                                            Perguntas Frequentes

                                                            Qual é o preço da ação de Novo Nordisk A/S hoje?

                                                            Qual é o código de ação de Novo Nordisk A/S?

                                                            O preço da ação de NVO está subindo?

                                                            Qual é a recomendação dos analistas para NVO?

                                                            Qual é o valor de mercado de NVO?

                                                            NVO divulga relatórios financeiros?

                                                            Quando será a próxima data de resultados de NVO?

                                                            Quais foram os lucros de NVO no último trimestre?

                                                            Qual foi a receita de NVO no último trimestre?

                                                            Qual foi o lucro líquido de NVO no último trimestre?

                                                            NVO paga dividendos?

                                                            Quantos funcionários NVO tem?

                                                            O que é o EBITDA de NVO?

                                                            Como comprar ações de NVO?

                                                            Devo investir nas ações da NVO?